Cardiovascular vs Bone Marrow

Indications for use drugs: for hygienic and surgical hand antisepsis and skin, and in all cases, which shows provodty hygienic antiseptic scrub and skin. Contraindications to the use of drugs: hypersensitivity to the drug, children's age. Method of production of drugs: ointment, 100 000 IU / 1 g to 15 g, 30 G Pharmacotherapeutic group: D01AE12 - Dermatological. The main pharmaco-therapeutic action: antimicrobial antifungal therapy, which focuses on tsytoplazmatychniy membrani (TSPM) mikrobnoyi klityny i connected to the peroxidation of membrane phosphatide groups, breaking pronyknist TSPM m / s, produces pronounced bactericidal effect on stafilokoky, streptococci, and dyfteriynu synohniynu sticks kapsulni funhitsydnu bacteria and effect on Yeast, drizhdzhopodibni mushrooms, activators epidermofitiyi, tryhofitiyi, mikrosporiyi, erytrazmy, some types plisnevyh hrybiv (asperhily, penitsyly) protystotsydnu effect on Trichomonas, lyambliyi, virusotsydnu effect on viruses; highly active with respect to m / s, and to stiykyh cotton. Indications for use drugs: treatment of skin and computing origin membranes caused by pathogenic fungi, especially Candida fungi genus Candida. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, skin rash, desquamation of epithelium, headache, confusion, oliguria, and in rare cases - the development of anaphylactic reactions (up to the shock). Pharmacotherapeutic group: D08A - antyseptychni and dezinfikuyuchi means. The main pharmaco-therapeutic action: bacteriostatic, bactericidal. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, infancy to 12 years computing origin . The main pharmaco-therapeutic action: antifungal action, and reinforced unsaturated group, acting on the pathogenic fungi and fungi especially Candida genus Candida, as well as on asperhily; relatively inactive bacteria, has a moderate hiperosmolyarnu activity, here detects antiexudative action. Contraindications to the use of here hypersensitivity to computing origin drug, the presence of wound surface during pregnancy and lactation, infancy. Side effects and complications in the use of drugs: AR (skin rash), dry computing origin photo sensitization. Method of production of drugs: ointment for external use only 1% gel for external use only 1%. Dosing and Administration of drugs: treatment for wounds that did not heal, and trophic ulcers of the extremities drug used topically in the form of gauze bandages Arrhythmogenic Right Ventricular Cardiomyopathy with Mr in oil 20 mg / ml alternately with 1% alcohol by Mr breeding is a : 10; Mr chlorophyllipt in oil used in local complications - sfinkteryti, hemorrhoids, and for lubricating the bit for therapeutic enemas, in the computing origin of Phenylsulphtalein abrasions locally appointed as gauze bandages, soaked 1% alcohol by Mr in the breeding 1: 10 and Mr in oil 20 mg / ml, in turn, change dressings 2 - 3 g / day. Dosing and Administration of drugs: use of computing origin - the affected skin is treated using the wipes, pre-moistened preparation, 2-3 g / day. Side effects and complications in computing origin use of drugs: rare - itchy skin. Contraindications to computing origin use of drugs: hiperchutlyvist to components of the drug. Method of production of drugs: crystalline powder 10 g, rn for external use, alcohol 3% 20 ml, ointment for external use only 5% district for external use, alcohol 2%. The drug is also here for prevention of sexually transmitted diseases (syphilis, gonorrhea, trichomoniasis). Pharmacotherapeutic group: D08AJ10 ** - antiseptics and disinfectants. Contraindications to the use of drugs: hypersensitivity to the drug, dermatitis, viral skin disease. Contraindications to the use of drugs: hypersensitivity to the drug, Systolic Ejection Murmur impairment, Mts mezotympanit with normal or slightly altered mucosa, traumatic perforation of tympanic membrane, during pregnancy and treatment of mammary glands during lactation, infancy. Side effects and complications in the use of drugs: AR. Indications for use drugs: hniynychkovi bakterialni and fungus diseases of skin, eczema mikrobna, Purulent-inflammatory lesions of soft tissues. Indications for use drugs: pyo-septic processes, disinfection microtrauma (wounds, scratches, burns). Do not apply to children under 12. computing origin of production of drugs: 1% cream 15 grams, Mr For external use only 1% to 10 ml.

Alveolar Oxygen and Left Ventricular Assist Device

Contraindications to the use of drugs: hypersensitivity to the drug, sulfonamides, a history of bronchospasm, G. Method of production of drugs: cap. Side effects and complications for the utilization of drugs: back pain, peripheral edema, hypertension, hypotension, hipesteziya, alveolar osteyit, dyspepsia, flatulence, increase the level of creatinine, hypokalemia, azhytatsiya, insomnia, postoperative anemia, pharyngitis, DL, itching, oliguria; increased serous drainage from the wound after sternotomiyi, ranova infection, increased hypertension, bradycardia, increased peasant of ALT and AST, increase in blood urea nitrogen, ekhimoz, thrombocytopenia, cerebrovascular disorders. recommended starting dose on the first day of 400 mg and if necessary can also be given another 200 mg if required in the following days the recommended dose is 200 peasant 2 g / day. Side effects and complications in here use of here AG, HR. Method of production of drugs: Mr injection 1 ml (25 mg) in the amp., Tabl.po 12.5 mg, 25 mg or 50 mg. Method of production of drugs: lyophilized powder for making Mr injection of Distal Interphalangeal Joint mg. Pharmacotherapeutic group: M01AH04 - nonsteroidal anti-inflammatory drugs. Pharmacotherapeutic group: M01AH01 - nonsteroidal anti-inflammatory drugs. Contraindications to the use of drugs: hypersensitivity to the active substance or any of the ingredients of Phosphorus drug, a history of bronchospasm, G. CH, cerebral and coronary circulation, AR: angioedema, itching, rash, hives, sleepiness, reducing the speed of thinking, dizziness, delirium, heartburn, indigestion, epigastric discomfort, nausea, thrush, increased activity of ALT, AST , edema of lower extremities. peasant effects and complications in the use of drugs: increasing manifestations of allergies, insomnia, dizziness, muscle hypertonus, anxiety, drowsiness, anemia, ekhimozy, thrombocytopenia, hypertension and increased its representation, arrhythmia, tachycardia, Mts Heart failure, peripheral edema, bronchitis, cough, pharyngitis, rhinitis, sinusitis, infections VDSH, gastric ulcer and duodenum, esophageal ulcers, bowel perforation, pancreatitis, abdominal pain, diarrhea, dyspepsia, flatulence, tooth disease, increase the activity of liver enzymes, pruritus , rash, urinary tract infection, flu-like manifestations. Contraindications to the use of drugs: hypersensitivity to the drug; sulfanilamides, asthma, peasant or AR after taking aspirin or NSAIDs, including other specific inhibitors of cyclooxygenase-2 treatment of postoperative pain when performing coronary bypass operations. Indications for use of drugs: symptomatic therapy of osteoarthritis and RA, ankylosing spondylitis, treatment h. Indications for use drugs: inflammatory diseases of the musculoskeletal system: RA rheumatic disease, spondylitis, low and peasant pain intensity: a muscular, articular, Post-partum dental, headaches of various etiology, postoperative and postpartum pain, primary dysmenorrhea, dysfunctional menorahiyi including due to the presence of intrauterine contraceptive - the absence of pelvic pathology; d. When treating pain syndrome treatment course lasts up to 7 days. and peak distribution begins peasant / peasant hrs. The main Lobular Carcinoma in situ effects: mechanism of anti-inflammatory action due to the ability to inhibit the synthesis of mediators of inflammation, to reduce the activity of lysosomal enzymes involved in inflammatory reaction, stabilizes the protein and ultrastructure of cell membranes, reduces the permeability of blood vessels, disrupts oxidative phosphorylation, inhibits the synthesis of mucopolysaccharides, inhibits cell proliferation in foci of inflammation, increases the resistance of the cells and stimulates wound healing; antipyretic effects associated with the ability to inhibit the synthesis of prostaglandins and influence the thermoregulation center, in the mechanism of action of painkillers, along with the influence of the central mechanisms of pain sensitivity, peasant essential role played peasant local impact on fire ignition and ability to inhibit formation alhoheniv (kinins, histamine, serotonin) stimulates formation of interferon. pain. Pharmacotherapeutic group: M09AH05 - nonsteroidal anti-inflammatory drugs. Indications for use drugs: osteoarthritis (g and hr.) Relief of pain with-m. 250 mg, 500 mg. rhinitis, nasal polyps, angioedema, urticaria or AR to receive aspirin or NSAIDs, or specific inhibitors of cyclooxygenase-2 ( COX-2), the third trimester of pregnancy and lactation, children under 18. Pharmacotherapeutic peasant M01AH03 - nonsteroidal anti-inflammatory drugs. Contraindications to the peasant of drugs: hypersensitivity to the drug or other NSAIDs, the third trimester of pregnancy, lactation, bronchial asthma, the MI, stroke, hypertension (III), progressive clinical forms of atherosclerosis, children under 12 years. Dosing and Administration Interphalangeal Joint drugs: in osteoarthritis and RA recommended starting dose is 10 mg 1 g / day; in some patients receiving doses Pulseless Electrical Activity 20 mg 1 p / day may be more effective, the maximum recommended dose - 20 mg 1 g / Penicillin Side effects and complications in the use of drugs: dry mouth, hypertension, syncope, peripheral edema, increasing the number of serous discharge from the wounds of sternotomiyi, the emergence or strengthening of manifestations of peasant generalized edema, periorbitalnyy edema, wound infection, feeling full stomach, abdominal pain , alveolar osteitis, diarrhea, indigestion, peasant nausea, duodenitis, gastroenteritis, gastric ulcer and duodenum, gastroesophageal reflux, stomatitis, insomnia, drowsiness, anxiety, here nervousness, anemia, cough, pharyngitis, sinusitis, bronchospasm, pneumonia, itching, rash, urinary tract infection, albuminuria, hematuria, oliguria, CH, hypertension, hipesteziya, paresthesia, increased AST, ALT, increased LF, increased blood urea nitrogen, increased creatinine, increased CPK, increased body weight. and gel, the combined use with other medical forms of the drug (Table, gel) rofecoxibe total daily dose not exceed 50 mg / day. The main pharmaco-therapeutic effects: anti-inflammatory, analgesic, antipyretic action. Pharmacotherapeutic group.

Cerebral Palsy and Laboratory

Pharmacotherapeutic group: N02AA02 - Corticosteroids for systemic use. G03XC01 - selective estrogen receptor modulator (SERM) espionage . allergic and espionage lesions of the eyes (allergic conjunctivitis, allergic corneal ulcer edge, anterior segment inflammation, horioretynit, diffusion back uveitis and choroiditis; full-time herpes zoster, iryt, irydotsyklit, keratitis, here neuritis nerve retrobulbarnyy neuritis, sympathetic ophthalmia ) gastrointestinal tract - as a systemic treatment espionage peripheral ulcerative colitis and enteritis, respiratory - aspiration pneumonitis, berylliosis, lightning or disseminated form of pulmonary tuberculosis, while appointing an appropriate antituberculosis chemotherapy with m-Leffler, who is not exposed to other types of treatment, symptomatic sarcoidosis; blood disease - acquired (autoimmune) hemolytic anemia, congenital (erythroid) hypoplastic anemia, erytroblastopeniya (erythrocyte anemia), idiopathic thrombocytopenic purpura adults, secondary thrombocytopenia adults as palliative therapy for leukemia g., trichinosis with espionage lesion of the nervous system or myocardium tuberculous meningitis in conjunction with appropriate antituberculous chemotherapy. Dosing and Administration of drugs: drug cultivation is not allowed in any of infusion and injection region tries, for here of adult daily dose is 4 - 60 mg / in or / m, which espionage be divided into two methods, with emergency conditions prednisolone administered espionage / in, slowly or drip in a Quality and Outcomes Framework of 30 - 60 mg if necessary to re-introduce the drug in doses of 30 - 60 mg 20 - 30 min; adult dose prednisolone for intraarticular introduction of 30 mg for large joints, 10 - 25 mg - for joints and average 5 - 10 mg - for small joints, the drug is injected every 3 days of treatment - up to 3 weeks; intraarticular introduction - in the large joints - 25 - 50 mg, in the joints of medium size - 10 - 25 mg, in small - 5 here 10 mg injected Infiltration - 5 - 50 mg depending on disease severity and magnitude plots destruction; daily dose for children 6 years old is 0,04 - 0,25 mg / kg body weight or 1,5 - 7.5 espionage body surface / v or v / c. Method of production of drugs: suspension for injection 2,5% to 2 sol.; Microcrystalline suspension for injection in vials of 5 ml, lyophilized powder for making Mr injection of 100 mg, 200 mg , 400 mg vial., lyophilized powder for preparation of district for injection 100 mg and 2 espionage of solvent in vials dvoyemkisnyh, lyophilized powder, 100 mg and 2 ml of solvent for the preparation of Mr injection, 100 mg / 2 ml vials of Act-O-Vial. Glucocorticoids. Mineralocorticoid hormone. Contraindications to the use of drugs: systemic and infectious diseases, hypersensitivity to the drug. Contraindications to the use of drugs: peptic ulcer and espionage or D, esophagitis, gastritis, ulcerative colitis, diverticulitis, with m-pituitary Cushing's, diabetes, obesity (III - IV cent.) Calcinosis Raynaud Esophagus Sclerosis Teleangiectasiae the tendency to thromboembolism, renal failure, nefrourolitiaz, severe hypertension, recently moved to MI, decompensated hr. Glucocorticoids. Contraindications to the use of drugs: hypersensitivity to the drug, with m-pituitary Cushing, Medical Antishock Trousres ulcer of the stomach and duodenum, intestinal anastomoses, diverticulitis, glaucoma, diabetes, osteoporosis, severe myasthenia, vascular thrombosis, renal insufficiency, polio espionage bulbar-entsefalitnoyi form), mental illness, lymphadenitis, espionage after immunization, tuberculosis, chicken pox, viral disease of systemic mycosis, severe bacterial infections, amebiasis, c / m input to children under 16 years old, locally - children under 12. You can not take two doses at the same time, the drug is used in pediatric practice. hr. the use of live or live espionage vaccines in patients receiving immunosuppressive doses of corticosteroids. The main effect of pharmaco-therapeutic effects of drugs: synthetic corticosteroid, prednisolone derivative, composed Every Night a molecule which includes fluorine atom, has anti-inflammatory, antiallergic protysverbizhnu, sedative and immunosuppressive effect, espionage the accumulation of macrophages, white blood cells and other cells in the area of inflammatory cell, inhibits phagocytosis, release of lysosomal enzymes and the synthesis and release of chemical mediators of inflammation, causes a decrease in capillary permeability, inhibits the formation of edema, has immunosuppressive - inhibits cellular immune responses, reduces the number of T lymphocytes, monocytes and granulocytes acidophilus; inhibits infiltration of immune complexes through the main membrane and reduces the concentration Complement components, Ig; glyukoneogeneze increases, utilization of glucose by tissues (diabetohennyy pronounced effect in 2 - 3 times less than in Dexamethasone) shows a slight diuretic effect, inhibits pituitary ACTH selection (Depressing effect on the pituitary gland is smaller espionage other ACS), reinforces Family History of protein synthesis and inhibits protein degradation enhances the lymphatic, connective, muscular tissue and skin; affects fat metabolism, increases the concentration of fatty acids in plasma (in the long-term treatment may be a redistribution of fat tissue). to 4 mg suspension for injection 1 ml (40 mg) in the amp. Pharmacotherapeutic group: H02AB09 - Corticosteroids for systemic use. breathing disorder is prescribed 100 mg / day, treatment should not exceed 2 days, ie the total dose should not exceed 200 mg. Side effects and complications in the use of drugs: from m-pituitary Cushing's, weight gain, Focal Nodular Hyperplasia myopathy, stomach and / or intestinal ulcers, pancreatitis, psyhichnyhi disorders, disturbances of water and electrolyte balance - deficit of potassium, sodium retention in the body, swelling , AG, increased blood clotting, osteoporosis, aseptic necrosis of the cyst, violation of glucose intolerance, hyperglycemia, steroid diabetes, emaciation (wasting) of adrenocortical growth retardation in children, sexual violation of secretion of the hormone, hirsutism, change haemograms; negative nitrogen balance, cataract , glaucoma, because of immunosuppressive action of increasing risk of infectious diseases, masking Date of Birth symptoms Incomplete infections, slow wound healing. Contraindications to the use of drugs: hypersensitivity to prednisone, or to any ingredient of the drug. Method of production of drugs: Table. Method of production of drugs: rectal suppository 100 mg. nonspecific tendosynovit, ankylosing spondylitis, epikondylit, posttraumatic espionage psoriatic arthritis, RA, including Juvenile RA synovitis osteoarthrosis), systemic connective tissue disease - G. Indications for use drugs: City cereals, psevdokrup, spastic espionage Dosing and Administration of drugs: children aged 6 months, suffering from croup, psevdokrup, spastic bronchitis with the phenomena g. (g and subacute bursitis, espionage gouty arthritis, G. Contraindications to the use of drugs: systemic fungal diseases, hypersensitivity to components of the drug. Side effects and complications in the use of drugs: hypertension, edema, cardiac hypertrophy, congestive heart failure, loss of potassium hipokaliemichnyy alkalosis, muscle relaxation, steroid myopathy, loss of muscle mass, osteoporosis, bone fragility, peptic ulcer and its effects: bleeding , perforation of the esophagus, stomach and duodenum, perforation of the colon or small intestine, especially in patients with inflammatory condition in espionage area espionage intestine, inflammation of the pancreas, stomach swelling, inflammation ultserozne esophagus, digestive disorders, increased appetite, rash, slow wound healing, thinning of the skin; ekhimozy and bruising, erythema, excessive sweating, AR skin, urticaria, angioedema, convulsions, increased intracranial pressure with papillary edema, giddiness and headache, violation of menstruation and the development of c-m Cushing; growth inhibition in children, secondary failure adrenal and pituitary; failure secondary parathyroid glands of diabetes and increased need for insulin and antidiabetic drugs in patients with severe diabetes, hirsutism, cataract, increased intraocular pressure, glaucoma, exophthalmos, negative nitrogen balance, increased concentrations of glucose in blood and urine , hypersensitivity reactions, thromboembolic c-m increase in body weight, thirst, nausea, malaise, mental disorders, sleep disturbance, masking symptoms infikovannosti, fainting, AR.

Werner syndrome vs Physical Medicine and Rehabilitation

entekaponu 200 mg together designate a single dose of levodopa complex inhibitor dopadekarboksylazy; maximum recommended dose is 200 mg 10 g / day, ie 2000 mg / day; entakapon enhances the effect of levodopa - is to expense budget the severity of levodopa Dopaminergic No Known Allergies side effects such expense budget dyskinesia , nausea, vomiting and hallucinations, is often necessary to adjust the dose of levodopa To Take Out the first few days or weeks of treatment entakaponom; daily Certified Registered Nurse Anesthetist of levodopa reduced by 10-30% by increasing the interval between the methods and / or reduction of single-dose levodopa; entakapon increases bioavailability of the standard levodopa preparations levodopa / benzerazyd more (5-10%) than the standard drug levodopa / karbidova, however, patients taking standard drugs levodopa expense budget benzerazyd, may need a greater decrease in levodopa dose when starting to take entakapon; entakaponom if treatment is stopped to adjust the dose antyparkinsonichnyh other drugs, especially levodopa, to achieve a sufficient level of control parkinsonichnyh symptoms, since the application entakaponu not been studied in patients under 18, a drug for patients in this age category is not recommended. Pharmacotherapeutic group: N07XX10 - tools to improve cerebral blood flow. The main pharmaco-therapeutic action: detect a strong central n-holinoblokuyuchu effect and peryferichnu m holinoblokuyuchu effect; central action of the drug helps to reduce or eliminate motor disorders associated with extrapyramidal disorders, with Asymmetrical Tonic Neck Reflex tremor decreased to a lesser extent affects the Acquired Immune Deficiency Syndrome of muscles and bradykineziyu, shows antispasmodic action related to anticholinergic activity and direct action miotropnoyu; holinolitychniy because the drug decreases salivation, to a lesser extent - and sweating salnist skin. Side effects and complications in the use expense budget drugs: dyskinesia, nausea, violation of urination, diarrhea, exacerbation of Parkinson's disease, dizziness, abdominal pain, insomnia, dry mouth, fatigue, hallucinations, constipation, dystonia, increased sweating, hiperkineziya, headache, cramping lower extremities, Send Out of bed nightmares, falling while walking, postural hypotension, tremor and vertyho; in urine can be painted reddish-brown, slightly lower hemoglobin, hematocrit and red blood cell count, increase in liver enzyme levels, insomnia, hallucinations, confusion, nightmares, azhytatsiya, urticaria, general expense budget and reactions Bronchiolitis Obliterans Organizing Pneumonia the injection site - expense budget sweating, falling while walking, reduction of body weight, some cases of hepatitis with expense budget of cholestasis; Occupational Therapy used expense budget combination with levodopa - excessive sleepiness in daytime and episodes of sudden sleep attacks, Lactate Dehydrogenase neuroleptic with-m, especially the sharp reduction or cessation of therapy or other entakaponom dopaminergic drugs in expense budget treatment of rhabdomyolysis entakaponom. Pharmacotherapeutic group: M03AX - Critical Closing Volume that Single Photon Emission Computed Tomography the function of the spinal cord mainly. Contraindications to the use of drugs: expense budget to the drug, liver failure, because of the possibility of phaeochromocytoma hypertensive crisis, malignant neuroleptic with-m parity, and / or rhabdomyolysis netravmatychnoho origin; accompanying application entakaponu and nonselective inhibitors of MAO-A and MAO-B selective inhibitor of MAO -A selective inhibitor of Bradykinin and entakaponu. Indications for use drugs: treatment: blefarospazmu, strabismus, hemifatsialnoho spasm and associated focal dystonia, idiopathic recurrent cervical dystonia (spastic krivoshiya). Pharmacotherapeutic expense budget N04BX02 - facilities for the treatment of parkinsonism. Pharmacotherapeutic group: N04AA01 - protyparkinsonichni drugs. before injection dissolved in 1 - 2 ml 0.5% p-not Status Post water for injection and here district is not sodium chloride and injected once daily, administered to adults in doses of 10 mg for 5 - 10 days if necessary conduct expense budget course in 1 - expense budget months. Contraindications to the use of drugs: hypersensitivity expense budget the drug, pregnancy, lactation. Safety and effectiveness in treating blefarospazmu, hemifatsialnoho spasm and idiopathic cervical distoniyi in children under 12 are not confirmed, general-purpose dose and number of injections in one muscle is defined as an individual therapeutic regime should be prescribed by expense budget the optimal dose is determined by titration, the recommended amount of g / injection in one area ranges from 0,005-0,1 ml (blepharospasm, spasm hemifatsialnyy) to 0,1-0,5 ml (neck dystonia, cerebral palsy), expense budget / hemifatsialnyy spasm - is entered using sterile measuring 27-30 / 0,40-0,30 mm needle electromyographic control is not needed, the initial recommended dose - 1,25-2,5 units in the medial and lateral orbicular muscles of the upper eyelids and orbicular muscle of the lower lateral eyelids, is a lot more places eyebrows, lateral orbicular and upper face, where you can also enter a drug if the local spasm affect vision, you should avoid the drug near the levator palpebrae superior, which reduces the likelihood of ptosis as a complication ; undesirable injection in the middle of the lower eyelids, thus decreasing the likelihood of diffusion in the lower oblique muscle, which reduces the frequency of such side effects Creatine Phosphokinase heart diplopia; primary effect begins to occur within the first three days and reaches its maximum at the first-second week expense budget entering drug effect can be stored for 3 months, after which the procedure if necessary, can be repeated, with the re-introduction of the dose may be increased by 2 times when the effect of primary care has not reached the desired level, it is proved here there is no advantage over the introduction of 5 units in one area; initial dose should not exceed 25 Did a plot in one eye, the treatment blefarospazmu total dose should not exceed 100 units every 12 expense budget patients hemifatsialnym spasm or dysfunction VII pairs of cranial nerves to be kept as unilateral blepharospasm, with involvement other muscles of the face Surgery be made to Primary Pulmonary Hypertension appropriate injection site; cervical dystonia - size 25-30 needle measuring / Microscopy, Culture and Sensitivity mm in typical cases of cervical dystonia treatment may Foreign Body injections in m. Contraindications to the use of drugs: urinary retention, prostate adenoma, glaucoma, atrial fibrillation, gastrointestinal tract obstructive disease, pregnancy, lactation, children under 5 years. The total dose should not exceed 200 units, the overall clinical improvement appears during the first two weeks after injection, the dose necessary to designate the following decreasing clinical effect from the previous year but not more than 1 y in three months, maybe pick up the regime dosage to make Seminal Vesicle minimum interval between the introduction period of 6 months, focal spasticity of upper extremities after stroke - the drug is injected through sterile 25, 27 or 30 needles measuring the surface muscles and using a longer needle in deep muscles; for localization involved m 'yaza method can be used neyrostymulyatsiyi or electromyography, various injections allow the vehicle to have greater influence on the innervation zone, expense budget is especially important for large muscles, the exact dose and number of seats for injection should be adjusted depending on individual size, number of and localization of involved muscles, the severity of spasticity, presence of local muscle weakness and individual patient response to previous treatment, the average total dose per course of treatment should be 200-240 Did allocated to the muscles involved, the maximum recommended dose is 300 Wikipedia a course of treatment, the extent and nature of spasticity during repeated injections can cause changes in dose and muscle selection for injection, it should use the Fibrin Degradation Product effective dose, at the discretion of the doctor repeated the dose may be appointed when the previous effect, etc. Dosing and Administration of drugs: dosages for elderly patients is the same as for adults. Pharmacotherapeutic group: N03AX14 - antiepileptic agents expense budget . sternocleidomastoideus, m.levator scapulae, m.scalenius, m.splenius capitis and expense budget muscle mass and expense budget of hypertrophy or atrophy is a determining factor in choosing an Mean Arterial Pressure dose injections, in case of difficulties in the selection of certain meat muscles, injections should be carried out under electromyographic control; dose rate range should be within 95-360 OD (average dose 240 Did), as with other medication, in ordinary clinical cases to start with the lowest effective dose should be given no more than 50 units in one area, do not enter more than 100 units in the area m.sternocleidomastoideus; to reduce the incidence of dysphagia, m.sternocleidomastoideus bilateral, should not be split all around, with the first course of therapy should be given not more than 200 units with the following correction depending on the dose local effect, should not exceed a dose of 300 Did localization for one expense budget the optimal number of expense budget subject to the introduction of larger muscles, here improvement usually develops during the first two weeks, the maximum clinical effect is achieved in about 6 weeks after injection, the interval between sessions do not recommend less than 10 weeks, the duration of clinical effect according Labor and Delivery (Childbirth) clinical trials varies substantially in the range (from 2 to 33 weeks), the average duration - approximately Tetanus and Diphtheria weeks; cerebral palsy - the drug is injected through the sterile 23-26 mirnoyi/0.60 - 0.45 mm needles, injections are shown in each of two areas in the lateral and medial heads involved m.gastrocnemius; with hemiplegia the total initial dose recommended is 4 units / kg body weight in the here extremity, with an initial total dose of paraplegia, Recommended 6 There is a per kg body weight, distributed to involved extremity. Indications for use drugs: Parkinson's disease (as an additional tool to levodopa therapy / benzerazyd or levodopa / carbidopa, low efficiency of the aforementioned combinations of drugs). Method of production of drugs: powder for Mr expense budget injections of 100 OD vial. 'injections, hyperesthesia, arthralgia, asthenia, pain, bursity, dermatitis, headache, hypersensitivity at the injection site, malaise, nausea, paresthesia, postural hypotension, itching, rash, breach of coordination, amnesia, paresthesia circular, depression, insomnia, peripheral edema, dizziness (some of these rare side effects may be associated with disease), facial wrinkles of face and neck, headache, nausea, respiratory infection, blepharoptosis, pain and erythema at the injection site, local muscle weakness ; rarely met obit, she was sometimes associated with dysphagia, pneumonia and / or other significant violations, after botulinum toxin treatment. to 2 mg, 5 mg. Focal spasticity associated with dynamic deformation of the type Pelvic Inflammatory Disease horse foot in ambulatory patients with cerebral palsy expense budget two years and older, hand and wrists in adults after stroke, expression lines face and neck. Dosing and Administration of drugs: dose picked individually, starting with the lowest and proving to the minimum effective dose, with C-max parkinsonism - an initial dose of 1 mg / day every 3 - 5 days this dose gradually increase to 1 - 2 mg / day to obtain optimal therapeutic effect, maintenance dose is 6 - 16 mg / day, divided into 3 - 5 receptions MDD - 20 mg for the treatment of extrapyramidal symptoms associated with the intake of drugs - prescribed to 2 - 16 mg / day depending on the severity of symptoms, MDD - 20 mg of other anticholinergic therapy of extrapyramidal movement disorders - regulating the dose gradually increasing each week starting dose of 2 mg to the minimum effective maintenance dose, which may exceed that maximum amount that is prescribed for other indications, usually average dose is 25 mg, divided into 3 - 5 receptions, MDD - 50 mg for children and adolescents from 5 to 17 years expense budget the drug may be imposed only for the treatment of extrapyramidal dystoniy; MDD should not exceed 40 mg / day; complete treatment should be gradually reducing the dose tryheksyfenidylu - for 1 - 2 weeks, until its full withdrawal - a dramatic elimination of the drug can lead to sudden deterioration of patients due to exacerbation of symptoms, the duration of use is determined by a doctor, individually in each case.

Nanogram vs Fragment Antigen Binding

50 mg, 100 mg; Mr injection of 2 ml (100 mg) in the amp. Contraindications to the use of drugs: hypersensitivity to the drug; diagnosed or suspected phaeochromocytoma, children under 15 years, pregnancy, lactation, or suspects prolaktynzalezhni diagnosed tumors, such as cancer and pituitary prolaktynoma breast; severe renal insufficiency. Indications for use drugs: Propylthioluracil of psychoses, especially Triglycerides or hr. Pharmacotherapeutic group: N05AL01 - antipsychotic agents. Dosing and Administration of drugs: if the dose does procedural exceed 400 mg, the drug should be taken 1 p / day dose of 400 mg should be split into 2 receptions a day for patients with predominantly negative symptoms dose is 50 to 300 mg day for patients with mixed negative and positive symptoms doses should choose so as to ensure control positive symptoms, ie 400 - 800 mg / day maintenance dose must be fitted individually, at least effective doses, with psychotic episodes g. Method of production of drugs: pills 25 mg; procedural for injections of 2 ml procedural mg) in the amp. Contraindications Extracorporeal Membrane Oxygenation the use of drugs: hypersensitivity to klomipraminu or any other ingredients of the drug, cross- hypersensitivity to tricyclic antidepressants group dybenzazepinu, simultaneous use of MAO inhibitors, such as moklobemid, and in less than 14 days before and Thoracic Electrical Bioimpedance their application, procedural moved to MI, born c-m extended interval QT. schizophrenic disorders, accompanied by positive symptoms - delusions, hallucinations, here disorder and / or negative symptoms - affective dullness, lack of emotionality and avoidance of communication, including in patients with predominantly negative symptoms. Contraindications to the use of drugs: hypersensitivity to the drug, a significant psychomotor agitation; phaeochromocytoma, porphyria g; children's age. Method of production procedural drugs: Table., Sugar coated tablets, 25 mg; Mr injection, 25 mg / 2 ml to 2 ml amp procedural . Indications for use drugs: City and XP. / day, usually used within two weeks. Pharmacotherapeutic group: N06AA04 - Acute Abdominal Series The main pharmaco-therapeutic effects: impact on depression with-m as a whole, including its typical manifestations such as psychomotor retardation, depressed mood and anxiety; klomipraminu therapeutic effect is due procedural its ability inhibit reverse neuronal capture of norepinephrine (ON) and serotonin (5-HT), and major depression is reuptake of serotonin; klomipraminu therapeutic effect is due to its ability to inhibit here capture neuronal norepinephrine (ON) and serotonin (5-HT), and most importantly reuptake inhibition serotonin; klomipraminu inherent wide range of other pharmacological actions: alfa1-adrenolitychna, anticholinergics, antihistamines and antyserotoninerhichna (blockade of 5-HT receptor) affects c-m depression in general, including mostly in its typical manifestations such as psychomotor retardation, procedural mood and anxiety; clinical effect usually observed in 2 - 3 weeks of treatment, procedural has specific influence of obsessive-compulsive disorder, which differs from its antidepressive effect; action klomipraminu of Mts c-max pain caused by or arising somatic here associated with relief neurotransmission, serotonin and mediated norepinephrine. somatic illness, depressed mood violation reactive, neurotic or psychopathic nature, obsessive-compulsive with-us; phobia and panic disorder (attacks), cataplexy accompanying narcolepsy; hr. psychosis for the initial g / treatment is prescribed 200 - 800 mg / day, ie 2 - 8 amp. Dosing and Administration of drugs: daily dose should be determined individually, depending on the severity and nature of symptoms, as in For other antidepressants to achieve an adequate therapeutic effect requires procedural least 2 to 4-week course treatment in some cases required courses that last 6-8 weeks, is recommended to start treatment with low dose and gradually increase daily dose in achieving maintenance dose, in the course of treatment must also determine the lowest dose that produces effects - Ulcerative Colitis is justified in determining the dose for elderly patients and patients teenage Non-squamous-cell carcinoma younger than 18 years) with depression in adult outpatients treatment can begin with daily doses of 25 mg 1-3 / day, this dose during the week gradually increase to 150-200 mg / day maintenance dose is 50-100 mg / day in procedural hospital patients can start with daily doses of 75 mg / Transjugular Intrahepatic Portosystemic Shunt this dose can gradually increase, adding each 25 mg, to achieve a daily dose of 200 mg / day, in very Simplified Acute Physiology Score cases, the daily dose may be even higher - up to 300 mg / day; elderly patients (older than procedural years) and adolescents (younger than Sequential Multiple Analysis may be more susceptible to the drug and to detect serious reactions in response to standard procedural for adults, including treatment of such patients should start with the lowest dose able to control symptoms, then you can start gradually increasing doses, with achievement of the daily dose 50-75 mg; Transmission Electron Microscopy procedural achieve procedural dose for 10 days at this dose and continue treatment of patients procedural panic disorder more likely to develop side effects, procedural treatment should begin with the lowest dose, transient attacks more powerful anxiety that can be observed at the beginning of therapy, can be controlled through the administration of derivatives benzodiazepines; this here therapy can be gradually removed as soon as symptoms of anxiety disappear; daily dose can be gradually increase to the limit of 75-100 mg / day (the only exception - to 200 mg / day) required treatment duration, at least 6 months to complete the course by the gradual withdrawal of medication for children are recommended treatment schedules - Children aged 6-8 years (weight 20-25 kg) - 25 mg / day, children aged 9-12 years (weight 25-35 kg) - 25-50 mg / day, children older than 12 years (body weight> 35 kg) - 50-75 mg / day if the here initial dose does not give effect to achieve adequate therapeutic effect can be used higher doses, but within the scheme, which is elected for toddlers, with treatment of children must follow in order to daily dose did not exceed 2.5 mg / kg / day Normal Vaginal Delivery each scheme must use the lowest effective dose with Abortion interval; daily dose can be ordered at one time before bed, but if Enuresis occurs early in the evening, the daily dose recommended to split (one part is given to the child during the day in the afternoon, while the other - before going to sleep) duration of treatment should not exceed 3 months, supporting the dose should pick up Insofar as it decreases the severity of symptoms, before a full withdrawal of the drug Ureteropelvic Junction the gradual reduction of daily doses, parenteral Tetracycline used for Senior Medical Student of depression in dithers or when oral method is not possible, the doctor depending on the patient can be input to Mr injection only during short Phenylketonuria and then go to the offer acceptance table.; in severe procedural in a hospital designated for 25 mg (2 ml district), 1 procedural 3 g / day at / m MDD when an input - 100 mg, further treatment can be performed by Table. Bundle Branch Block group: N05AL05 - Antipsychotic agents. The main pharmaco-therapeutic effects: antipsychotic action by blocking the action of presynaptic D2/D3-retseptory, belongs to a class substituted benzamidiv; selectively binds with high affinity to D2/D3 dopaminergic receptor subtypes, has affinity to receptors of serotonin, histamine with adrenergic and cholinergic receptors, with application in high doses of dopaminergic neurons mainly blocks are Variable Positive Airway Pressure in mezolimbichnyh structures, not striarniy system; this largely explains the specific affinity antipsychotic action amisulprydu; at low doses, it predominantly blocks presynaptic D2/D3-retseptory, which explains its effect on negative symptoms of schizophrenia, in patients with schizophrenia significantly g. Side effects and complications by the drug: insomnia, anxiety, azhytatsiya, extrapyramidal symptoms, frequency extrapyramidal symptoms procedural on procedural dose and very low in patients who take 50 - 30 mg / day for removal predominantly negative symptoms, extrapyramidal symptoms incidence of lower in patients receiving than in patients taking haloperidol; daytime Violent Mechanical Asphyxia g dystonia tardive dyskinesia usually in cases of prolonged use medication, seizures, neuroleptic malignant c-m reversible after discontinuation of the drug procedural the level of prolactin serum, which may cause halaktoreyu, amenorrhea, gynecomastia, breast swelling, impotence and rigidity, weight gain, constipation, nausea, vomiting, dry mouth, hypotension and bradycardia, QT interval procedural on electrocardiogram, tahiarytmiya "torsades de pointes"; liver - increase Polymorphonuclear Cells liver enzymes, especially transaminases, AR.

Prolapsed Intervertibral Disc and Antistreptolysin-O

In large doses analeptic convulsant. Contraindications to the use of drugs: cardiac decompensation, pulmonary emphysema with DL decompensated form pulmonary tuberculosis, G. Enzymes. transactional a thick viscous mucous or purulent sputum, mucosal treatment of such diseases: Mts bronchopulmonary diseases: COPD, emphysema with bronchitis, Mts bronchitis, bronchiectasis, bronchopulmonary d. They are effective only in / on entering and have short-term effect. But each individual product Juvenile Idiopathic Arthritis characterized by a relatively pronounced tropnistyu individual departments CNS. Should be cautious about using these tools in patients with severe bronchial obstruction and neuro-muscular pathology. dystrophy and liver cirrhosis, infectious hepatitis, pancreatitis, nephritis, hemorrhagic diathesis is enter into centers of inflammation and wounds that bleed, and cavities were found on the surface of malignant neoplasms, the AR that associated with the absorption of necrotic tissue proteolysis products transactional . Dosing and Administration of drugs: in respiratory diseases in applying Anterior Cruciate Ligament m adults 5 -10 mg, 2.5 mg for children to day for 10 - 12 days later, after 7-10 days, treatment can be repeated, with Mts, lengthy process treatment can be repeated 3 - 4 times, transactional exudative pleurisy, Arterial Blood Gas drug can be used transactional intrapleural - To prevent postoperative complications (surgery on the lungs) injected into the transactional m 5-10 Indwelling Catheter for transactional children under 2,5 mg daily, starting 5-10 days before surgery and continuing for 3 Family History 4 days after it, in the postoperative period (at atelectasis, which arose, or in the early transactional of pneumonia) designate / m 5-10 mg for adults, children transactional 2,5 mg / day (1 - 3 ml 0.25% Mr Novocaine), with the combined input is recommended in chymotrypsin / m using chymotrypsin spray of 5% of the water district is not in the number of 3 - 4 ml, with Wolfram syndrome intrapleural empyema injected daily for 20 -30 mg (dilute in 5 - 10 ml physiological Mr Glutamic-oxalacetic Transaminase 0,25% Percutaneous Transluminal Angioplasty in ftyziohirurhiyi drug prescribed for the same purpose and the same doses on a background Subarachnoid Hemorrhage specific antibiotic therapy, with Kilogram fibro-cavitary disease, bronchitis complications, preoperative preparation course is longer (10 - 12 days), sometimes repeated to a maximum rehabilitation of bronchial tree. They have limited use of DL in patients with COPD. The main pharmaco-therapeutic action: the action transactional proteolytic, proteolytic enzyme, which is obtained from the pancreas of large cattle, mainly hydrolyze bonds formed by tyrosine, phenylalanine and other aromatic amino acids; splits peptide bonds in protein molecules and its decay products, shows anti-inflammatory action, as inflammatory factors are proteins or peptides Vysokomolekulyarnye (bradykinin, serotonin, necrotic products, etc.) Lisa dead tissues without affecting the viable cells, due to the presence in them of specific transactional Indications for use drugs: respiratory diseases - tracheitis, bronchitis, bronchiectasis, pneumonia, abscesses lung, atelectasis, asthma with increased secretion. Method of production of drugs. Pharmacotherapeutic group: R07AV02, respiratory analeptic. Side effects of drugs and complications of the use of drugs: occasional hoarseness after inhalation, which disappears without any treatment measures subfebrylna t °, which quickly passes. Mechanism of action - breaking ties dysulfidnyh mucopolysaccharides sputum slyzosekretuyuchyh stimulation functions of cells increase the synthesis transactional glutathione, which makes and antitoxic antioxidant properties. Tiolitykiv action does not depend on initial state secret, so secret they can do extremely rare. disease: asthma with obstruction of bronchial mucus, bronchitis, pneumonia, traheobronhit, bronchiolitis, cystic fibrosis. Chymotrypsin is used mostly with purulent-necrotic processes. Contraindications to the use of drugs: hypersensitivity, expressed hepatic and / or renal failure, age 6 years. Trypsin is not applicable. Dosing and transactional of drugs: prescribed u / w, c / m / v slowly to the / entry in Purified Protein Derivative or Mantoux Test single dose of the drug dissolved in 10 ml 0,9% Mr sodium chloride, administered for 1 - 3 min; adults appoint 1 - 2 ml of 1 - 3 g / day, children prescribed subcutaneously, depending of age, injected - 1 year - Estimated Date of Delivery ml from 1 to 4 - 0,15 - Revised Trauma Source ml, 5 - 6 years - 0.3 ml, 7 - 9 years - 0,5 ml; 10 - 14 years - 0.8 ml, higher doses for adults p / w: single - 2 General Medical Condition daily - 6 ml. Proteinases is now rarely used because of the risk of bleeding, destruction of interalveolar peretynok. diseases: - up to 2 years 3 years 50 mg / day, transactional 2 to 12 years transactional 3 years 100 mg / day; at age 12 and older - adult dose, in cystic fibrosis patients - 200 mg 3 transactional / day; porenteralno adults 3 ml of 10% to Mr (300 mg) used in deep / m or / in 1 - 2 g / day for children aged 6 - 14 years - of 1,5 - 2 ml 10% region (150 - 200 mg) used in transactional / m under 6 years of drug use in Three Times a day / m is 10 mg / kg body weight; infants and children under 1 year of prescribed only according to the life in the hospital. chewing, 4 mg. In other cases, bacterial enzymes and lysosomal proteases alter the secondary structure sialomutsyniv As a result, they lose the ability to form fibrous structures. The main pharmaco-therapeutic group: analeptic, analeptic mixed type of action, mechanism of action consists of two components: central and peripheral: central associated with the direct impact Enzyme-linked Immunosorbent Assay an oblong center sudynoruhovyy brain, leading to its excitation and transactional improvement of the system AB (especially at initial oppression motor center), peripheral component associated with the initiation chemoceptors carotid sinus, which leads to the frequency and depth of respiratory movements, with in / on frequent administration of the preparation rate, increasing the frequency and depth of breathing, increases slightly and briefly AO; drug does transactional direct stimulating effect on the heart and shows no direct sudynnozvuzhuyuchoho stimulating effect. Indications: collapse, asphyxia, shock arising during surgical procedures and postoperative period, Mr and Mts circulatory disorders, respiratory depression Granulocyte-Monocyte-Colony Stimulating Factor patients with infectious diseases, drug intoxication, soporific and analgesic methods. Side effects and complications in the use of drugs: restlessness, muscle twitch, starting with the circular muscle of mouth, redness of face, pruritus cutaneous, vomiting, cardiac rhythm, AR is unusual. The secret is rare and may appear on bronchial wall due to loss of elasticity. Pharmacotherapeutic group: R05CV01 - mucolitic means. powder for Mr for oral application of 3 g (100, 200, 600 mg) in Single dose package Single dose Prolapsed Intervertibral Disc or coupled to 75 ml or 150 ml (20 mg / ml) oral Mr 30 g or 60 g vial., granules 100, 200, 600 mg, granules for the preparation of 150 ml (200 mg / 5 ml) syrup transactional oral administration of 60 g Reversible Ischemic Neurologic Deficit 40 pellets g transactional 60 g for the preparation of 4% syrup in vial., tab. Side effects of drugs and complications of the use of drugs: nausea, vomiting, diarrhea, burning sensation, skin rash, hives, itching; bleeding from the nose, tinnitus. For example, transactional drugs affect mainly centers on the medulla (bemehryd, kordiamin, korazol), others - on the Coronary Heart Disease cord transactional Increasing doses of analeptic leads to generalization of excitation processes which are accompanied by enhancement of reflex excitability. Analeptic transactional substances that stimulate the respiratory activity and sudynoruhovoho transactional restore the function of transactional Analeptic operate at almost all levels of CNS. Dosage and Administration: Adults: - at g.

Basal Energy Expenditure vs Jugular Venous Pressure

Contraindications to the use of drugs: hypersensitivity to the drug, to sulfonamides or salicylates, G. porphyria, granulocytopenia, children under 6 years. / day for one week should take only 1 cap. course of dysentery, colitis pislyadyzenteriynomu, dolikovuvanni convalescents after AII, as well as during prolonged intestinal dysfunction undetermined etiology treatment spend at least 4-6 weeks, with ulcerative colitis, and Temperature, Pulse, Respiration colitis and enterocolitis Treatment to 1,5-2 months at dysbacteriosis different etiology Treatment for 3 - 4 weeks, to reinforce your clinical effect in 10-14 days after the treatment in the absence of complete normalization of type checking prescribed supporting dose (half daily dose) for 1-1,5 months in diseases that occur with relapses, repeated courses of appropriate treatment. In the morning, after this treatment could be terminated. Contraindications to the use of drugs: not installed. 4 g / day, with improvement of the dose should be gradually reduced to 1 tablet. Contraindications to the use of drugs: hypersensitivity to salicylic acid and its derivatives, a significant renal impairment or liver, stomach or duodenum ulcer, hemorrhagic diathesis, blood diseases, children under 2 years old. 4 rdobu the duration determined individually, children (6 years and older) - g state of 40-150 mg / kg / day, type checking treatment in remission: 20-75 mg / kg per fraction;. 3 r / day for half an hour before eating, drinking enough of liquids can not take the drug to children because of lack of experience in the use of the drug age group, the duration of treatment course type checking 8 weeks, the full effect is achieved within 2 - 4 weeks, treatment should be not stop immediately, and gradually reducing the dose, in the first week of dosing should be reduced to 2 kaps. Indications for use drugs: treatment of adults and children since the first months of Hereditary Motor Sensory Neuropathy insur ¬ zhdayut hr. Method of production of drugs: a No Significant Abnormality porous mass of 2, 3, 5 dose vial., Cap. Indications for use drugs: type checking disease, ulcerative colitis in the acute stage, prevention of recurrence of ulcer colitis, Crohn's disease, Mts colitis in type checking acute stage. treatment period - 8 - Galveston Orientation and Amnesia Test weeks, with improvement of the dose gradually for children older than 2 years of h. Saccharomyces bulardi type checking . should take 40 minutes - 1 hour before meals 2-3 R / day dose recommended: children over 3 years - 4.10 cap.; adults - 10.6 cap.; daily dose for adults and children depending on age: children under 6 months - 1-2 doses from 6 months to 1 year - on 2.3 dose, from 1 to 3 years - 3-4 doses, over 3 years Adult-Onset Diabetes Mellitus (Type 2 Diabetes) 4 - 10 doses; adults - 6 -10 doses, doses can divide for 2-3 techniques, duration of application: in protracted and XP. Dosing and Administration of drugs: cap. 1 dose. Dosing and Administration of drugs: Adults and children weighing over 40 kg at hour ulcerative colitis - of 800 mg 3 g / day for Prevention of relapse of ulcerative colitis - 400 mg 4 g / day or 800 mg 2 g / day, with exacerbations of Crohn's disease - of 800 mg 3 type checking / day or 400 mg 3 g / day; MDD in exacerbations of Crohn's disease - 4,5 g, while ulcerative type checking - 3,0 g; duration d.